loader
Please Wait
Applying Filters...
menu
    • menu

    Setid 5f3574d9 A70c 5923 E053 2991aa0a64ed Applno 20972 Form Capsule Oral Dosage 200mg - Drug Product Composition: Sustiva

    Menu

    Sustiva

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    ANALYTICAL

    PharmaCompass
    $ API Ref.Price (USD/KG) : 105Xls

    Filters

    clear-filterReset all filters
    SearchXls

    USFDA APPLICATION NUMBER - 20972 / DOSAGE - CAPSULE;ORAL - 200MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    EFAVIRENZ(UNII: JE6H2O27P8)
    (EFAVIRENZ - UNII:JE6H2O27P8)     		EFAVIRENZ50mg | 200mg

    Inactive Ingredients

    Ingredient Name
    Aesica Queenborough Limited
    LACTOSE MONOHYDRATE(EWQ57Q8I5X)
    MAGNESIUM STEARATE(70097M6I30)
    SODIUM LAURYL SULFATE(368GB5141J)
    SODIUM STARCH GLYCOLATE TYPE A POTATO(5856J3G2A2)